Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.
about
The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysisViral hepatitis and hepatocellular carcinomaEvidence for hepatitis C viral infection in patients with primary hepatocellular carcinomaStructure-Based Mutational Analysis of the Hepatitis C Virus NS3 HelicaseHepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis CSuppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cellsEffects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virusHepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experienceMolecular mechanisms underlying occult hepatitis B virus infection.Hospice palliative care for patients with hepatocellular carcinoma in Taiwan.Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish populationInterval to vascularization development in cirrhotic precursor nodules in patients with hepatitis B and C virus co-infectionsSeroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients.Chronic viral hepatitis.Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes.Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis CPositive association between hepatitis C infection and oral cavity cancer: a nationwide population-based cohort study in Taiwan.Hepatitis C: an epidemiological review.Cancer epidemiology and control in Taiwan: a brief review.Geographic patterns of hepatocellular carcinoma mortality with exposure to iron in groundwater in Taiwanese population: an ecological studyAntioxidative status of patients with alcoholic liver disease in southeastern Taiwan.Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients.Hepatitis B virus infection and primary hepatocellular carcinoma.An increased standardised mortality ratio for liver cancer among polyvinyl chloride workers in Taiwan.Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors in married couples, a bordered province of western Thailand: Hepatitis B seromarkers, hepatitis C antibody, and risk behaviorsIncreased morbidity odds ratio of primary liver cancer and cirrhosis of the liver among vinyl chloride monomer workers.Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virusChanging disease burden of hepatocellular carcinoma in the Far East and Southeast Asia.One-Year Mortality after Traumatic Brain Injury in Liver Cirrhosis Patients--A Ten-Year Population-Based Study.Viral etiology of hepatocellular carcinoma and HCV genotypes in Taiwan.Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan.Treatment of chronic hepatitis C in southern Taiwan.Anti HCV seroprevalence among the voluntary blood donors in Thailand.Coinfection of TT virus and response to interferon therapy in patients with chronic hepatitis B or C.Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.Prevalence and factors of elevated alanine aminotransferase in central Taiwan - a retrospective study.Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis C.Dual chronic hepatitis B virus and hepatitis C virus infection.
P2860
Q21245094-6C0DDDCE-35A6-4FB3-939B-6EC6AC66FD36Q21245597-6CDF5A7F-85C4-4B9E-B95D-5221930D2532Q27469317-CBECB294-4402-49DE-B776-40E7E701B311Q27469958-E0C95112-466D-4FB8-9880-C81D754439AAQ27472769-8874B06D-CE21-4A9D-B82E-F083C8F714B5Q27473528-7DEC6EB0-F9E5-47D9-84AC-119C92B17B40Q27486067-2E4C0EA8-2DD0-4CC0-8565-DDB83B8A2C28Q27487987-A0C8A497-5B15-4D2F-BF9E-CD224158A446Q27490250-9D17D497-4694-4AD4-8899-FE4A722EC0A0Q27686923-EF0637F5-65F0-4A63-9CC0-6006AA0EB558Q33360149-D1E9D9BD-804E-4979-9060-19B55682BA87Q33373735-EBC856BE-FEB8-4ACD-9F58-1B16DCBB7D7BQ33617717-5496EDDB-3C68-496D-9E02-4BF79A00AD5EQ33773121-EECB3F1E-A336-4D0E-85C3-C7A766251930Q33783711-F71F6D1A-D435-485C-BE1E-485C76111A33Q33929138-F67EC642-5177-461B-A58D-886E999AEDBAQ33965808-B706737E-85B0-426B-BE4D-D62A13637262Q34438231-688FE2A8-3E80-4239-88CF-2A3470D3EAA6Q34469335-0EF5E760-C582-4881-92E6-722AD1F9513DQ34551348-9DF67918-76E0-4D3C-AFC1-C9D8D6356E87Q34604977-4E0BD904-8FD2-4EFC-9978-453457C9A747Q34670565-179362E4-CAD1-4ABD-9BF8-311371D529E8Q34670902-0D17CD2F-5F5C-4761-96F1-2362BBF4A3D0Q34876460-C153153D-4B63-4853-9119-8F36249C021CQ35231554-3AE621CF-BB66-48A3-B823-3AD993CA5D34Q35495849-818067F6-8202-4D37-9FC0-25800A1391F8Q35507734-97909C56-9B17-4F34-9F8B-E7ACC0B152BDQ35560861-055C8132-BE89-4667-95AF-55AD323BF97AQ35833159-3C4AD297-1B3C-4ED2-8270-1C26FD5BF079Q36184218-12F8A3D7-B128-42C4-8FD3-03134F539FE4Q36195323-B23C6A13-7D27-4BDA-8A0B-FBA58AC2CD4EQ36258740-CCF9FAC5-811D-4456-90F8-889D9EC61ECDQ36258744-F8B64122-FACE-4766-A8CA-D77B97696F10Q36258748-092C72CD-82D1-41D7-BCBA-B5E4DEB043C9Q36307590-146239A1-BCE3-4A6A-877D-9A45377418C0Q36308604-3F4755D5-0609-49DA-85FD-33B41FF51351Q36617917-421B218A-3E1C-4B9A-AA3E-C1F7AAE9236BQ36894903-52FC15C7-FDBA-42D0-8168-D056BB870738Q37243485-26CE550E-0503-401E-BC73-BB6583EF80D0Q37466211-28F455E0-52C7-4D7F-BD91-F75B4F2C8A71
P2860
Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Hepatitis C virus infection in ...... isease: the Taiwan experience.
@en
Hepatitis C virus infection in ...... isease: the Taiwan experience.
@nl
type
label
Hepatitis C virus infection in ...... isease: the Taiwan experience.
@en
Hepatitis C virus infection in ...... isease: the Taiwan experience.
@nl
prefLabel
Hepatitis C virus infection in ...... isease: the Taiwan experience.
@en
Hepatitis C virus infection in ...... isease: the Taiwan experience.
@nl
P2093
P356
P1476
Hepatitis C virus infection in ...... isease: the Taiwan experience.
@en
P2093
P304
P356
10.1093/INFDIS/162.4.817
P407
P577
1990-10-01T00:00:00Z